DarioHealth (DRIO) stock price, revenue, and financials

DarioHealth market cap is $20.9 m, and annual revenue was $7.39 m in FY 2018

$20.9 M

DRIO Mkt cap, 10-Jun-2019

$1.7 M

DarioHealth Revenue Q2, 2019
DarioHealth Gross profit (Q2, 2019)326 K
DarioHealth Gross profit margin (Q2, 2019), %19.7%
DarioHealth Net income (Q2, 2019)-5.4 M
DarioHealth EBIT (Q2, 2019)-5.4 M
DarioHealth Cash, 30-Jun-20198 M

DarioHealth Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

51.0k823.0k2.8m5.2m7.4m

Revenue growth, %

1514%241%

Cost of goods sold

2.3m3.4m3.9m5.6m

Gross profit

(2.2m)(561.0k)1.3m1.8m

Gross profit Margin, %

(4359%)(20%)25%24%

Sales and marketing expense

4.7m7.7m10.3m

R&D expense

4.9m2.6m2.2m3.3m3.7m

General and administrative expense

6.3m2.9m3.4m4.7m5.5m

Operating expense total

11.2m6.8m10.3m15.7m19.5m

EBIT

(11.4m)7.7m11.1m14.4m17.7m

EBIT margin, %

(22271%)935%396%279%239%

Net Income

13.9m(12.9m)7.1m10.9m15.7m17.8m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

67.0k175.0k273.0k568.0k669.0k728.0k1.0m1.2m1.4m1.8m2.1m1.9m2.2m1.7m

Cost of goods sold

297.0k670.0k826.0k652.0k901.0k850.0k1.1m1.2m1.5m1.4m1.7m1.3m

Gross profit

(230.0k)(102.0k)(157.0k)76.0k106.0k360.0k276.0k552.0k522.0k468.0k558.0k326.0k

Gross profit Margin, %

(343%)(18%)(23%)10%11%30%20%31%25%25%25%20%

Sales and marketing expense

252.0k519.0k1.1m1.5m1.8m2.2m1.7m1.8m2.3m2.7m3.9m3.0m

R&D expense

1.1m1.1m1.3m769.0k883.0k441.0k667.0k397.0k521.0k659.0k469.0k1.2m797.0k742.0k1.0m997.0k1.0m991.0k

General and administrative expense

1.4m854.0k1.3m901.0k412.0k574.0k1.3m905.0k803.0k605.0k2.0m1.1m781.0k861.0k2.9m709.0k973.0k1.7m

Operating expense total

2.5m1.9m3.0m1.9m1.5m1.3m2.4m1.8m2.5m2.8m4.3m4.5m3.3m3.4m6.2m4.4m5.9m5.7m

Depreciation and amortization

155.0k

EBIT

2.7m3.6m2.5m1.8m1.5m2.5m1.9m2.6m2.7m(4.2m)(4.1m)(3.0m)(2.9m)(5.7m)(3.9m)(5.4m)(5.4m)

EBIT margin, %

2652%864%933%339%392%374%(418%)(340%)(217%)(164%)(278%)(209%)(239%)(325%)

Net Income

3.5m3.0m3.3m3.1m1.6m2.0m1.8m1.2m2.7m1.7m(5.4m)(4.1m)(3.0m)(2.9m)(5.8m)(4.1m)(5.4m)(5.4m)

DarioHealth Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

2.3m1.5m2.7m1.1m3.7m11.0m

Accounts Receivable

99.3m

Inventories

601.0k888.0k1.2m1.4m

Current Assets

2.9m2.1m4.3m2.9m6.0m13.3m

PP&E

1.1m978.0k749.0k901.0k869.0k733.0k

Total Assets

4.1m3.1m5.1m3.9m7.0m14.1m

Accounts Payable

586.3k708.0k978.0k37.9m1.9m2.6m

Current Liabilities

1.5m1.6m1.7m2.9m3.0m5.2m

Additional Paid-in Capital

19.9m30.8m41.8m48.4m74.9m98.2m

Retained Earnings

(20.0m)(36.1m)(43.4m)(55.0m)(71.0m)(89.3m)

Total Equity

(86.4k)(5.3m)(1.6m)(6.5m)3.9m8.9m

Financial Leverage

-47.6 x-0.6 x-3.2 x-0.6 x1.8 x1.6 x

DarioHealth Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(13.9m)(12.9m)(7.1m)(10.9m)(15.7m)(17.8m)

Depreciation and Amortization

839.2k549.0k335.0k387.0k195.0k207.0k

Inventories

(366.0k)(287.0k)(295.0k)(193.0k)

Cash From Operating Activities

(7.6m)(8.6m)(6.3m)(8.4m)(10.6m)(11.5m)

Purchases of PP&E

(1.4m)(563.0k)(110.0k)(808.0k)(195.0k)(71.0k)

Cash From Investing Activities

(1.6m)(429.0k)(113.0k)(947.0k)(219.0k)6.0k

Cash From Financing Activities

10.3m8.2m7.6m7.7m13.5m18.7m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

3.5m(3.0m)(6.2m)(9.3m)(1.6m)(3.6m)(5.5m)(1.2m)(3.9m)(5.6m)(5.4m)(850.0k)(12.5m)(2.9m)(8.8m)(12.8m)(5.4m)(10.8m)

Depreciation and Amortization

198.0k358.0k461.0k79.0k163.0k248.0k102.0k191.0k273.0k44.0k101.0k155.0k53.0k101.0k160.0k46.0k93.0k

Inventories

(109.0k)(81.0k)(404.0k)(517.0k)(36.0k)

Cash From Operating Activities

(2.3m)(4.4m)(6.2m)(1.5m)(2.8m)(4.2m)(2.1m)(3.8m)(6.5m)(3.1m)(5.8m)(8.2m)(2.8m)(4.8m)(8.0m)(4.0m)(9.5m)

Purchases of PP&E

(116.0k)(150.0k)(219.0k)(36.0k)(46.0k)(70.0k)(35.0k)(246.0k)(406.0k)(31.0k)(64.0k)(12.0k)(23.0k)(49.0k)(45.0k)(71.0k)

Cash From Investing Activities

(116.0k)(130.0k)(125.0k)(29.0k)(49.0k)(65.0k)(27.0k)(245.0k)(560.0k)(9.0k)(38.0k)(77.0k)55.0k20.0k(52.0k)(78.0k)

Cash From Financing Activities

4.0m4.1m8.2m2.0m2.4m4.7m7.7m7.7m7.7m4.8m8.7m13.5m6.0m6.0m15.7m6.6m

DarioHealth Ratios

USDY, 2019

Financial Leverage

2 x

DarioHealth Operating Metrics

FY, 2016

Patents (US)

2